The Discounted Cash Flow (DCF) valuation of Genovis AB (GENO.ST) is 15.14 SEK. With the latest stock price at 28.55 SEK, the upside of Genovis AB based on DCF is -47%.

Is GENO.ST a buy or a sell?

Based on the latest price of 28.55 SEK and our DCF valuation, Genovis AB (GENO.ST) is a sell. Selling GENO.ST stocks now will result in a potential gain of 47%.

	Range	Selected
WACC / Discount Rate	5.1% - 8.2%	6.7%
Long-term Growth Rate	3.0% - 4.9%	3.9%
Fair Price	8.78 - 146.63	15.14
Upside	-69.3% - 413.6%	-47.0%

28.55 SEK

Stock Price

15.14 SEK

Fair Price

REVENUE & EXPENSES

CAPEX

D&A

WORKING CAPITAL

TERMINAL VALUE

GENO.ST DCF Valuation: Revenue & Expenses Forecast

(SEK in millions)		Projections

	12-2024	12-2025	12-2026	12-2027	12-2028	12-2029

Revenue	130	142	182	206	227	246
% Growth	18%	9%	28%	13%	10%	9%

Cost of goods sold	(46)	(48)	(58)	(63)	(65)	(67)
% of Revenue	35%	34%	32%	30%	29%	27%

Selling, G&A expenses	(45)	(49)	(62)	(71)	(78)	(85)
% of Revenue	34%	34%	34%	34%	34%	34%

Research & Development	0	0	0	0	0	0
% of Revenue	0%	0%	0%	0%	0%	0%

Net interest & other expenses	7	8	10	11	12	13
% of Revenue	5%	5%	5%	5%	5%	5%

Tax expense	(13)	(15)	(21)	(24)	(28)	(31)
Tax rate	29%	29%	29%	29%	29%	29%

Net profit	33	38	50	59	68	76
% Margin	25%	27%	28%	29%	30%	31%